Kolon Life Science Inc banner
K

Kolon Life Science Inc
KOSDAQ:102940

Watchlist Manager
Kolon Life Science Inc
KOSDAQ:102940
Watchlist
Price: 61 100 KRW 0.33% Market Closed
Market Cap: ₩791.2B

Balance Sheet

Balance Sheet Decomposition
Kolon Life Science Inc

Balance Sheet
Kolon Life Science Inc

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
6 873
7 646
11 008
16 237
14 920
38 967
16 097
19 940
5 060
27 009
137 740
55 825
32 671
5 914
15 001
27 800
6 371
7 480
12 417
Cash
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
Cash Equivalents
6 873
7 646
11 008
16 237
14 920
38 967
16 096
19 940
5 060
27 009
137 740
55 825
32 671
5 914
15 001
27 800
6 371
7 480
12 417
Short-Term Investments
0
1 200
0
0
0
0
0
456
0
0
111
23 000
5 100
15 000
30
110
0
0
0
Total Receivables
4 270
5 648
5 388
13 566
24 632
30 167
24 745
22 197
18 941
17 273
21 469
21 943
24 685
29 507
22 647
20 304
30 029
25 634
37 808
Accounts Receivables
3 445
4 589
4 252
12 317
22 979
20 161
19 691
20 074
17 893
17 212
21 395
20 972
23 127
29 022
22 199
19 921
29 584
24 822
36 820
Other Receivables
825
1 059
1 136
1 249
1 653
10 006
5 054
2 123
1 048
61
74
971
1 558
485
448
383
445
812
989
Inventory
8 716
10 644
15 756
15 619
19 115
27 868
35 830
43 285
42 592
36 251
34 734
46 532
37 427
36 064
42 790
45 998
68 494
67 777
46 726
Other Current Assets
527
396
634
610
340
239
689
971
2 265
1 845
2 761
3 676
5 833
8 805
20 094
3 809
5 291
4 154
5 103
Total Current Assets
20 386
25 534
32 785
46 031
59 007
97 241
77 361
86 848
68 857
82 379
196 816
150 976
105 717
95 290
100 563
98 021
110 184
105 045
102 055
PP&E Net
945
5 244
14 465
24 662
31 859
45 651
103 968
108 257
113 064
116 686
125 562
144 249
166 350
178 398
141 893
131 481
125 960
123 138
115 076
PP&E Gross
945
5 244
14 465
24 662
0
0
103 968
108 257
113 064
116 686
125 562
144 249
166 350
178 398
141 893
131 481
125 960
123 138
115 076
Accumulated Depreciation
156
468
1 107
2 335
0
0
19 075
16 926
25 000
34 161
40 182
50 582
67 978
80 978
92 290
106 538
113 901
122 880
139 050
Intangible Assets
568
871
827
591
2 189
2 149
2 079
3 309
7 800
10 411
11 808
17 140
8 426
900
722
502
343
333
599
Goodwill
4 510
4 004
3 498
2 992
2 992
2 992
2 992
2 992
2 992
2 992
2 992
2 992
1 894
1 217
1 217
1 217
1 217
0
0
Note Receivable
766
1 161
1 411
1 553
1 482
0
0
0
0
0
0
0
0
0
9
0
0
0
1 460
Long-Term Investments
3
3
303
454
472
469
4 415
3 951
14 656
14 656
14 545
400 520
335 701
2 140
3 262
2 549
75 240
79 924
200 019
Other Long-Term Assets
2 084
1 050
1 765
2 519
1 033
1 066
1 480
1 540
1 526
1 491
2 848
920
815
350
671
889
1 174
996
354
Other Assets
4 510
4 004
3 498
2 992
2 992
2 992
2 992
2 992
2 992
2 992
2 992
2 992
1 894
1 217
1 217
1 217
1 217
0
0
Total Assets
29 262
N/A
37 866
+29%
55 055
+45%
78 802
+43%
99 035
+26%
149 568
+51%
192 296
+29%
206 898
+8%
208 896
+1%
228 616
+9%
354 573
+55%
716 797
+102%
618 903
-14%
278 295
-55%
248 338
-11%
234 658
-6%
314 118
+34%
309 436
-1%
419 563
+36%
Liabilities
Accounts Payable
3 423
4 244
3 370
7 133
9 175
10 299
7 992
11 646
7 134
7 532
10 277
11 701
10 268
10 714
11 808
13 774
17 049
11 547
11 950
Accrued Liabilities
25
31
92
83
302
523
719
1 213
1 384
1 380
1 417
1 601
1 943
1 898
2 721
3 145
3 594
4 355
4 908
Short-Term Debt
3 000
5 000
7 000
0
14 583
10 855
12 377
11 767
11 903
11 574
13 444
30 417
32 940
53 742
61 751
59 064
69 461
97 262
105 890
Current Portion of Long-Term Debt
667
1 333
1 858
2 707
2 040
4 140
4 404
16 469
13 675
14 550
28 917
8 233
7 512
6 753
5 682
5 670
4 288
429
10 686
Other Current Liabilities
4 097
4 801
9 232
5 884
4 976
7 910
14 557
5 205
3 439
3 405
16 157
11 105
24 346
53 065
63 189
13 816
15 185
14 748
72 821
Total Current Liabilities
11 212
15 409
21 552
15 807
31 076
33 728
40 050
46 301
37 536
38 441
70 212
63 056
77 009
126 173
145 152
95 469
109 578
128 341
206 255
Long-Term Debt
3 333
2 000
4 342
7 650
5 610
40 165
43 196
33 466
30 476
48 242
18 625
10 392
24 615
18 237
9 595
4 191
167
10 172
10 022
Deferred Income Tax
0
0
0
0
0
269
0
0
0
0
0
90 763
68 297
0
0
0
9 760
9 874
33 629
Other Liabilities
2 613
3 740
4 877
5 999
4 232
2 071
2 351
3 503
4 710
6 492
5 948
7 173
2 836
32 864
35 633
35 588
26 890
23 377
20 319
Total Liabilities
17 158
N/A
21 150
+23%
30 771
+45%
29 456
-4%
40 918
+39%
76 232
+86%
85 597
+12%
83 270
-3%
72 721
-13%
93 174
+28%
94 784
+2%
171 384
+81%
172 757
+1%
177 274
+3%
190 381
+7%
135 248
-29%
146 395
+8%
171 764
+17%
270 225
+57%
Equity
Common Stock
1 600
1 641
1 641
2 001
2 041
2 143
2 574
2 639
3 345
3 345
3 805
3 805
5 706
5 706
5 706
5 706
5 706
5 706
6 212
Retained Earnings
1 268
4 719
12 308
21 149
30 051
40 777
59 014
72 285
76 763
76 031
86 412
83 314
32 666
61 361
104 359
106 024
101 537
133 289
228 091
Additional Paid In Capital
9 235
10 356
10 335
26 101
26 098
30 565
45 341
48 942
56 417
56 417
169 922
169 922
167 980
167 980
167 980
209 542
209 114
209 114
218 918
Unrealized Security Profit/Loss
0
0
0
84
0
0
14
5
0
0
0
288 722
240 606
10 493
10 557
9 001
54 440
56 140
152 299
Treasury Stock
0
0
0
0
97
168
245
245
351
351
351
351
813
813
813
813
0
0
0
Other Equity
0
0
0
11
23
19
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
12 104
N/A
16 716
+38%
24 284
+45%
49 346
+103%
58 117
+18%
73 336
+26%
106 698
+45%
123 628
+16%
136 175
+10%
135 442
-1%
259 788
+92%
545 412
+110%
446 146
-18%
101 020
-77%
57 957
-43%
99 410
+72%
167 723
+69%
137 672
-18%
149 338
+8%
Total Liabilities & Equity
29 262
N/A
37 866
+29%
55 055
+45%
78 802
+43%
99 035
+26%
149 568
+51%
192 296
+29%
206 898
+8%
208 896
+1%
228 616
+9%
354 573
+55%
716 797
+102%
618 903
-14%
278 295
-55%
248 338
-11%
234 658
-6%
314 118
+34%
309 436
-1%
419 563
+36%
Shares Outstanding
Common Shares Outstanding
5
5
5
8
8
8
10
10
10
10
11
11
11
11
11
11
11
11
12
Preferred Shares Outstanding
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0